Home
Storia in 2 fonti
Pfizer and Arvinas give disappointing breast cancer drug to Rigel
Pfizer and its partner Arvinas are selling rights to their recently approved breast cancer drug to Rigel Pharmaceuticals.
- ·
biopharmadive.com
Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drug
A deal with Rigel Pharmaceuticals ends months of uncertainty about the future of Veppanu, a first-of-its-kind, newly approved medicine with a murky financial outlook.
- ·
endpoints.news
Pfizer and Arvinas give disappointing breast cancer drug to Rigel
Pfizer and its partner Arvinas are selling rights to their recently approved breast cancer drug to Rigel Pharmaceuticals.